Published in Medical Letter on the CDC and FDA, March 17th, 1997
Within two months, the hospital hopes to win clearances and federal grant money to conduct a trial of the therapy that includes anti-viral drugs AZT and 3TC. The highly effective protease inhibitors, which came into widespread usage in the past year, are not to be included in the study at first.
Participants in the study would be uninfected people who believe they were exposed to HIV within the previous 72 hours during an isolated incident of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.